Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1997 1
1998 1
1999 1
2000 2
2001 3
2002 4
2003 1
2004 2
2005 2
2006 1
2007 3
2008 2
2010 1
2011 3
2012 6
2013 3
2014 1
2015 2
2016 4
2017 1
2019 5
2020 2
2021 3
2022 3
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

56 results

Results by year

Filters applied: . Clear all
Page 1
Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
Daly MB, Pal T, Berry MP, Buys SS, Dickson P, Domchek SM, Elkhanany A, Friedman S, Goggins M, Hutton ML; CGC; Karlan BY, Khan S, Klein C, Kohlmann W; CGC; Kurian AW, Laronga C, Litton JK, Mak JS; LCGC; Menendez CS, Merajver SD, Norquist BS, Offit K, Pederson HJ, Reiser G; CGC; Senter-Jamieson L; CGC; Shannon KM, Shatsky R, Visvanathan K, Weitzel JN, Wick MJ, Wisinski KB, Yurgelun MB, Darlow SD, Dwyer MA. Daly MB, et al. J Natl Compr Canc Netw. 2021 Jan 6;19(1):77-102. doi: 10.6004/jnccn.2021.0001. J Natl Compr Canc Netw. 2021. PMID: 33406487
The NCCN Guidelines for Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic focus primarily on assessment of pathogenic or likely pathogenic variants associated with increased risk of breast, ovarian, and pancreatic cancer …
The NCCN Guidelines for Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic focus primarily on asses …
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2024.
Daly MB, Pal T, Maxwell KN, Churpek J, Kohlmann W, AlHilli Z, Arun B, Buys SS, Cheng H, Domchek SM, Friedman S, Giri V, Goggins M, Hagemann A, Hendrix A, Hutton ML, Karlan BY, Kassem N, Khan S, Khoury K, Kurian AW, Laronga C, Mak JS, Mansour J, McDonnell K, Menendez CS, Merajver SD, Norquist BS, Offit K, Rash D, Reiser G, Senter-Jamieson L, Shannon KM, Visvanathan K, Welborn J, Wick MJ, Wood M, Yurgelun MB, Dwyer MA, Darlow SD. Daly MB, et al. J Natl Compr Canc Netw. 2023 Oct;21(10):1000-1010. doi: 10.6004/jnccn.2023.0051. J Natl Compr Canc Netw. 2023. PMID: 37856201
The NCCN Guidelines for Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic focus primarily on assessment of pathogenic/likely pathogenic (P/LP) variants associated with increased risk of breast, ovarian, pancreatic, and prost …
The NCCN Guidelines for Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic focus primarily on asses …
Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.
US Preventive Services Task Force; Owens DK, Davidson KW, Krist AH, Barry MJ, Cabana M, Caughey AB, Doubeni CA, Epling JW Jr, Kubik M, Landefeld CS, Mangione CM, Pbert L, Silverstein M, Simon MA, Tseng CW, Wong JB. US Preventive Services Task Force, et al. JAMA. 2019 Aug 20;322(7):652-665. doi: 10.1001/jama.2019.10987. JAMA. 2019. PMID: 31429903
IMPORTANCE: Potentially harmful mutations of the breast cancer susceptibility 1 and 2 genes (BRCA1/2) are associated with increased risk for breast, ovarian, fallopian tube, and peritoneal cancer. ...CONCLUSIONS AND RECOMMENDATION: …
IMPORTANCE: Potentially harmful mutations of the breast cancer susceptibility 1 and 2 genes (BRCA1/2) are associ …
Surgical Management of Hereditary Breast Cancer.
Berger ER, Golshan M. Berger ER, et al. Genes (Basel). 2021 Aug 31;12(9):1371. doi: 10.3390/genes12091371. Genes (Basel). 2021. PMID: 34573353 Free PMC article. Review.
The identification that breast cancer is hereditary was first described in the nineteenth century. With the identification of the BRCA1 and BRCA 2 breast/ovarian cancer susceptibility genes in the mid-1990s and the introduction of genetic …
The identification that breast cancer is hereditary was first described in the nineteenth century. With the identification of the BRC …
Familial gastric cancer: genetic susceptibility, pathology, and implications for management.
Oliveira C, Pinheiro H, Figueiredo J, Seruca R, Carneiro F. Oliveira C, et al. Lancet Oncol. 2015 Feb;16(2):e60-70. doi: 10.1016/S1470-2045(14)71016-2. Lancet Oncol. 2015. PMID: 25638682 Review.
Familial gastric cancer comprises at least three major syndromes: hereditary diffuse gastric cancer, gastric adenocarcinoma and proximal polyposis of the stomach, and familial intestinal gastric cancer. ...Gastric cancer is also associate …
Familial gastric cancer comprises at least three major syndromes: hereditary diffuse gastric cancer, gastric adenocarci …
A new paradigm of genetic testing for hereditary breast/ovarian cancers.
Kwong A, Chen JW, Shin VY. Kwong A, et al. Hong Kong Med J. 2016 Apr;22(2):171-7. doi: 10.12809/hkmj154634. Epub 2016 Mar 14. Hong Kong Med J. 2016. PMID: 26980575 Free article. Review.
Publications available online until January 2015 that addressed issues related to hereditary breast/ovarian cancer genetic counselling/testing were selected. The search terms used were "familial breast/ovarian cancer", "suscepti …
Publications available online until January 2015 that addressed issues related to hereditary breast/ovarian cancer gene …
Universal Genetic Testing for All Breast Cancer Patients.
Copur MS. Copur MS. Oncology (Williston Park). 2019 Aug 23;33(8):683731. Oncology (Williston Park). 2019. PMID: 31469901 Free article.
Women with pathogenic BRCA1/2 mutations are more likely to develop breast cancer than are women without the mutation and they typically develop cancer at an earlier age. ...The US Preventive Services Task Force and the National Comprehensive Cancer Net …
Women with pathogenic BRCA1/2 mutations are more likely to develop breast cancer than are women without the mutation and they …
Hereditary Cancer Syndromes-A Primer on Diagnosis and Management: Part 1: Breast-Ovarian Cancer Syndromes.
Samadder NJ, Giridhar KV, Baffy N, Riegert-Johnson D, Couch FJ. Samadder NJ, et al. Mayo Clin Proc. 2019 Jun;94(6):1084-1098. doi: 10.1016/j.mayocp.2019.02.017. Mayo Clin Proc. 2019. PMID: 31171119 Review.
Hereditary causes occurring due to pathogenic sequence variants and defects in certain genes makes up roughly 5% of all colorectal cancers and breast-ovarian cancers. High-risk hereditary predisposition syndromes have been associated with a substantial …
Hereditary causes occurring due to pathogenic sequence variants and defects in certain genes makes up roughly 5% of all colorectal cancer …
How I Do It: Genetic counseling and genetic testing for inherited prostate cancer.
Giri VN, Gross L, Gomella LG, Hyatt C. Giri VN, et al. Can J Urol. 2016 Apr;23(2):8247-53. Can J Urol. 2016. PMID: 27085833 Free article. Review.
Therefore, family history indicating inherited prostate cancer predisposition may extend beyond prostate cancer to include other cancers such as breast, ovarian and others. Genetic counseling and genetic testing guidelines for prostate …
Therefore, family history indicating inherited prostate cancer predisposition may extend beyond prostate cancer to incl …
Investigating men's motivations to engage in genetic screening for BRCA1 and BRCA2 mutations.
Annoni AM, Longhini C. Annoni AM, et al. PLoS One. 2022 Mar 18;17(3):e0265387. doi: 10.1371/journal.pone.0265387. eCollection 2022. PLoS One. 2022. PMID: 35303741 Free PMC article.
BRCA1 and BRCA2 mutations are associated with an increased risk of developing numerous cancers, including breast, ovarian, pancreatic, melanoma and prostate cancer. Men face BRCA-related cancer risks as women do. However, there is considerably l …
BRCA1 and BRCA2 mutations are associated with an increased risk of developing numerous cancers, including breast, ovarian …
56 results